Federal Grant Opportunities
80,922 opportunities from Grants.gov – 527 currently open for applications. Data from SAM.gov and Grants.gov, covering federal grant programs and opportunities across all 50 states; see our methodology.
527 Open 80,395 Closed
All Opportunities
Page 17 of 1,619 Open National Institutes of Health
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Posted: Nov 25, 2024 Closes: May 7, 2027 CFDA 93.286;93.396;93.865;93.866
Open National Institutes of Health
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
Posted: Nov 25, 2024 Closes: Jan 7, 2028 CFDA 93.242;93.279;93.307;93.361;93.393;93.396;93.399;93.866
Open National Institutes of Health
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
Posted: Nov 25, 2024 Closes: Jan 7, 2028 CFDA 93.242
Open National Institutes of Health
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
Posted: Nov 25, 2024 Closes: Jan 7, 2028 CFDA 93.242
Closed National Institutes of Health
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
Posted: Nov 25, 2024 Closes: May 7, 2026 Up to $450K CFDA 93.273
Closed National Institutes of Health
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
Posted: Nov 25, 2024 Closes: May 7, 2026 CFDA 93.273
Open Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Training Project Grants (T03)
Posted: Nov 22, 2024 Closes: Oct 26, 2028 Up to $550K CFDA 93.262
Open National Institutes of Health
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Posted: Nov 22, 2024 Closes: Dec 23, 2027 Up to $350K CFDA 93.233;93.837;93.838;93.839
Open National Institutes of Health
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Posted: Nov 22, 2024 Closes: Dec 23, 2027 CFDA 93.233;93.837;93.838;93.839
Open National Institutes of Health
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Posted: Nov 22, 2024 Closes: Dec 23, 2027 CFDA 93.233;93.837;93.838;93.839
Open National Institutes of Health
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Posted: Nov 22, 2024 Closes: Dec 23, 2027 CFDA 93.233;93.837;93.838;93.839
Open National Institutes of Health
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Posted: Nov 22, 2024 Closes: Dec 23, 2027 CFDA 93.233;93.837;93.838;93.839
Open National Institutes of Health
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Posted: Nov 22, 2024 Closes: Jan 7, 2028 CFDA 93.242;93.313
Open National Institutes of Health
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Posted: Nov 22, 2024 Closes: Jan 7, 2028 CFDA 93.242;93.313
Open National Institutes of Health
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Posted: Nov 22, 2024 Closes: Nov 19, 2026 CFDA 93.242
Open National Institutes of Health
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Posted: Nov 22, 2024 Closes: Jan 7, 2028 Up to $200K CFDA 93.242
Open National Institutes of Health
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Posted: Nov 22, 2024 Closes: Jan 7, 2028 CFDA 93.242
Open National Institutes of Health
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
Posted: Nov 21, 2024 Closes: Jan 7, 2027 Up to $250K CFDA 93.242;93.879
Closed National Institutes of Health
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Posted: Nov 21, 2024 Closes: May 4, 2026 Up to $475K CFDA 93.394;93.395
Open National Institutes of Health
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Posted: Nov 21, 2024 Closes: Jan 7, 2028 CFDA 93.172;93.173;93.233;93.242;93.273;93.279;93.361;93.393;93.394;93.395;93.396;93.399;93.837;93.838;93.839;93.840;93.865;93.866;93.867
Open National Institutes of Health
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Posted: Nov 21, 2024 Closes: May 7, 2027 CFDA 93.121;93.273;93.279;93.307;93.313;93.399
Open National Institutes of Health
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Posted: Nov 21, 2024 Closes: Nov 17, 2026 Up to $350K CFDA 93.213
Open National Institutes of Health
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Posted: Nov 21, 2024 Closes: Nov 17, 2026 CFDA 93.213
Closed National Institutes of Health
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Posted: Nov 21, 2024 Closes: May 7, 2026 CFDA 93.399
Open National Institutes of Health
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Posted: Nov 21, 2024 Closes: Nov 17, 2026 CFDA 93.213
Open National Institutes of Health
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Posted: Nov 21, 2024 Closes: Oct 8, 2027 CFDA 93.393
Open National Institutes of Health
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Posted: Nov 21, 2024 Closes: Jan 7, 2028 CFDA 93.242
Open National Institutes of Health
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Posted: Nov 21, 2024 Closes: Jan 7, 2028 CFDA 93.242
Closed National Institutes of Health
BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
Posted: Nov 21, 2024 Closes: Jun 17, 2026 CFDA 93.173;93.213;93.242;93.273;93.279;93.286;93.853;93.865;93.866;93.867
Open National Institutes of Health
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Posted: Nov 20, 2024 Closes: Nov 18, 2027 Up to $300K CFDA 93.233;93.279;93.837;93.838;93.839;93.840;93.855
Open National Institutes of Health
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Posted: Nov 20, 2024 Closes: Nov 19, 2026 CFDA 93.853
Open National Institutes of Health
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Posted: Nov 20, 2024 Closes: Oct 14, 2027 CFDA 93.398
Open National Institutes of Health
NICHD Small Research Grant Program (R03 Clinical Trial Required)
Posted: Nov 18, 2024 Closes: Jan 7, 2028 Up to $50K CFDA 93.865
Open National Institutes of Health
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Posted: Nov 18, 2024 Closes: Jan 7, 2028 Up to $50K CFDA 93.865
Open National Institutes of Health
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Nov 12, 2027 Up to $350K CFDA 93.279
Open National Institutes of Health
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Sep 7, 2026 CFDA 93.242
Open National Institutes of Health
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Posted: Nov 18, 2024 Closes: Sep 7, 2026 CFDA 93.242
Open National Institutes of Health
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Sep 7, 2026 CFDA 93.242
Open National Institutes of Health
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Posted: Nov 18, 2024 Closes: Sep 7, 2026 CFDA 93.242
Closed National Institutes of Health
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Posted: Nov 18, 2024 Closes: May 7, 2026 CFDA 93.242;93.279;93.313;93.855;93.865
Closed National Institutes of Health
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Posted: Nov 18, 2024 Closes: May 7, 2026 CFDA 93.279;93.313;93.855;93.865
Open National Institutes of Health
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Sep 7, 2027 CFDA 93.173;93.865
Open National Institutes of Health
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Sep 7, 2027 CFDA 93.173;93.865
Closed National Institutes of Health
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: May 7, 2026 Up to $75K CFDA 93.351
Open National Institutes of Health
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Jan 7, 2028 CFDA 93.393
Open National Institutes of Health
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Nov 16, 2027 CFDA 93.393
Open National Institutes of Health
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Sep 7, 2027 CFDA 93.172;93.879
Open National Institutes of Health
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Posted: Nov 18, 2024 Closes: Sep 7, 2027 CFDA 93.172;93.879
Open National Institutes of Health
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
Posted: Nov 18, 2024 Closes: Sep 7, 2026 CFDA 93.242
Open National Institutes of Health
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
Posted: Nov 18, 2024 Closes: Sep 7, 2026 CFDA 93.242
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |